Dr. Anthony Tuan Nguyen, MD, PhD

Dr. Nguyen practices at Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System.

Dr. Nguyen's NPI, 1992293468, was assigned on April 30, 2018. Dr. Nguyen graduated from Harvard Medical School in 2018. Dr. Nguyen holds California license A164051.

Dr. Nguyen's primary practice is Cedars-Sinai Medical Center, at 8700 Beverly Blvd, Los Angeles, CA 90048 in Los Angeles County. The practice phone is (310) 423-5000.

Dr. Nguyen's primary practice is Cedars-Sinai Medical Center in Los Angeles, California, part of Cedars-Sinai Health System. The medical group on file is Cedars-Sinai Medical Center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Nguyen practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Nguyen's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Nguyen is board certified in radiation oncology by the American Board of Radiology. Dr. Nguyen is licensed in California.

Dmand AI lists pancreatic cancer radiation among the conditions Dr. Nguyen treats.

CMS data shows 483 Medicare services from Dr. Nguyen across 12 procedure codes in 2024, for 68 Medicare patients. Medicare paid $36,135 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 68 Medicare patients who saw Dr. Nguyen in 2024. The largest group is 65 to 74, with 41 patients. 75% of them have cancer, and 75% have high blood pressure. 32% are also on Medicaid. Their average risk score is 2.18, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Nguyen's median patient age at 73, with 17% women.

In 2024, Dr. Nguyen wrote 43 Medicare Part D claims for 12 patients. 79% of them were for generic drugs. CMS names the drug for 22 of them, across 1 drug with 11 or more claims each, at $118 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 93 out of 100 for Dr. Nguyen for performance year 2024, reported as part of a group. Dr. Nguyen accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Nguyen as offering telehealth.

Dmand AI links 15 papers to Dr. Nguyen, published from 2012 to 2023. 2023 was the busiest year, with 3. The most frequent topics are Brachytherapy, Radiotherapy Dosage and Breast Neoplasms. Dr. Nguyen has published most often in Brachytherapy. Dr. Nguyen's most frequent co-authors are Mitchell Kamrava, MD, Stephen Lawrence Shiao, MD and Katelyn Mae Atkins, MD.

CMS Open Payments shows 29 general payments to Dr. Nguyen from 10 drug and device companies from 2024 to 2025. Device or supply loans make up the largest share, 46% of the total. International Rehabilitative Sciences, Inc paid the most, $3,385. It also lists 3 research payments totaling $2,601 from 2024 to 2025.

Dr. Nguyen graduated from Harvard Medical School in 2018. Dr. Nguyen is a member of AACR, ASTRO, ASCO and Society for Immunotherapy of Cancer.

Dr. Nguyen is in network with 11 carriers, including United Healthcare, Elevance and Aetna. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.